-The Hindu Kochi: The Kerala Agricultural University has found "dangerous levels" of pesticide residue in key vegetables like cabbage, cauliflower, vegetable cowpea (achinga), amaranthus red, small red onions, tomatoes, green chillies and curry leaves, among others. The residue includes that of the banned Profenofos, which falls into the yellow category (second level of pesticides in the toxicity classification) and which has translaminar action (the toxin entering the plant system primarily by roots,...

-The Telegraph The Union health ministry has banned the manufacture and sale of a pain-reliever called dextropropoxyphene (DPPP) amid steadily growing concerns worldwide that this opioid analgesic drug poses several serious health risks, including heart damage. The health ministry, in a drug withdrawal notification, has suspended the manufacture, distribution and sale of all medicines containing DPPP saying the central government has determined that this drug is likely to involve risk to humans...

-The Hindu Business Line   Arsenic and fluoride contaminated water has condemned millions to live wasted lives in West Bengal, Andhra Pradesh and Karnataka. Business Line visited several villages in the affected regions for this special report by A. Srinivas. Sixty-nine-year-old Renubala Ari of Deganga village in West Bengal's North 24 Parganas district is counting her last days. But it is not her death that worries her. Blind in both eyes and with painful...

-The Hindu     Antibiotics are often used as an excuse for poor infection control Arjun (name changed) is an 8-year-old boy who was being treated for breathing difficulty in a hospital in one of the southern cities. He had suffered on and off with cough/cold since infancy and had been treated multiple times with antibiotics. His parents were not highly educated and hoped that he would get better as he grew older. This...

-The Hindu The lesson from the Supreme Court ruling on Gleevec is that pharmaceutical multinational corporations need to focus research on genuine innovations rather than on ways to evergreen their patents The much awaited Supreme Court judgment on Gleevec has been delivered. Novartis has failed in reversing the rejection of its patent. And, predictably - like a scratched record - there have been suggestions that pharma investments in India will dry...